Jun Morita

487 total citations
36 papers, 371 citations indexed

About

Jun Morita is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Jun Morita has authored 36 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Pharmacology. Recurrent topics in Jun Morita's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Cancer Cells and Metastasis (5 papers) and Urologic and reproductive health conditions (5 papers). Jun Morita is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Cancer Cells and Metastasis (5 papers) and Urologic and reproductive health conditions (5 papers). Jun Morita collaborates with scholars based in Japan, Australia and United States. Jun Morita's co-authors include Yoshio Ogawa, Michio Naoe, Robert H. Johnson, Sanju Iwamoto, Takashi Fukagai, Kumiko Takeshita, Atsushi Yanaihara, Akira Miyazaki, Hideki Yoshida and Atsushi Igarashi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and British Journal of Cancer.

In The Last Decade

Jun Morita

34 papers receiving 357 citations

Peers

Countries citing papers authored by Jun Morita

Since Specialization

Citations

This map shows the geographic impact of Jun Morita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Morita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Morita more than expected).

Fields of papers citing papers by Jun Morita

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Morita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Morita. The network helps show where Jun Morita may publish in the future.

Co-authorship network of co-authors of Jun Morita

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Morita. A scholar is included among the top collaborators of Jun Morita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Morita. Jun Morita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Current Status of Sequential Treatment for Castration-resistant Prostate Cancer: A Retrospective Analysis 2025 ·Cancer Diagnosis & Prognosis ·(unknown), (unknown), (unknown), (unknown), (unknown), Yoshihiro Nakagami, (unknown), (unknown), (unknown), Jun Morita, (unknown), (unknown), Katsuyuki Saito, (unknown), (unknown), Takashi Fukagai	1
2	Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment 2024 ·Cancer Chemotherapy and Pharmacology ·(unknown), Takuya Araki, (unknown), (unknown), Jun Morita, (unknown), Masayuki Ohbayashi, Noriko Kohyama, Yoshio Ogawa, Takashi Fukagai, Koujirou Yamamoto, (unknown)	1
3	Urethral hemangioma: How to investigate as a cause of hematuria after male sexual activities 2023 ·IJU Case Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), Yu Hashimoto, (unknown), (unknown), (unknown), Jun Morita	1
4	Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios alone or combined with prostate-specific antigen for the diagnosis of prostate cancer and clinically significant prostate cancer 2022 ·Asian journal of urology ·(unknown), (unknown), Takashi Fukagai, Yoshio Ogawa, Yoshihiro Nakagami, (unknown), Jun Morita, (unknown), (unknown), (unknown), Tetsuo Noguchi, (unknown), (unknown), Satoshi Amano, (unknown), (unknown), (unknown), (unknown)	3
5	Prognostic model for overall survival that includes the combination of platelet count and neutrophil–lymphocyte ratio within the first six weeks of sunitinib treatment for metastatic renal cell carcinoma 2022 ·BMC Cancer ·(unknown), (unknown), Y. Kanda, Kaori Takano, Masayuki Ohbayashi, Noriko Kohyama, Jun Morita, (unknown), (unknown), Yoshio Ogawa, (unknown)	3
6	Hard bilateral syphilitic testes with vasculitis: a case report and literature review 2021 ·BMC Urology ·(unknown), (unknown), Takashi Fukagai, (unknown), Jun Morita, (unknown), (unknown), Yoshihiro Nakagami, (unknown), Tetsuo Noguchi, (unknown), (unknown), Satoshi Amano, (unknown), (unknown), (unknown), (unknown), Yoshio Ogawa	3
7	MRI-guided conservative management of a left segmental testicular infarction 2021 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Yoshio Ogawa, (unknown), Yoshihiro Nakagami, Jun Morita, (unknown), (unknown), (unknown), (unknown), (unknown), Satoshi Amano, (unknown)	1
8	Prostate cancer detection rate and Gleason score in relation to prostate volume as assessed by magnetic resonance imaging cognitive biopsy and standard biopsy 2020 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Yoshio Ogawa, Michio Naoe, (unknown), (unknown), Jun Morita, (unknown), (unknown), (unknown), (unknown), (unknown)	4
9	A Case of Hyperammonemia in a Patient with Urinary Tract Infection and Urinary Retention 2020 ·Urological Science ·(unknown), (unknown), (unknown), (unknown), Michio Naoe, Yoshio Ogawa, (unknown), (unknown), (unknown), (unknown), Jun Morita, (unknown), (unknown)	4
10	A Novel, Circulating Tumor Cell Enrichment Method Reduces ARv7 False Positivity in Patients with Castration-Resistant Prostate Cancer 2020 ·Diagnostics ·(unknown), (unknown), (unknown), (unknown), Kumiko Ueda, (unknown), (unknown), Jun Morita, (unknown), (unknown), Michio Naoe, Yoshio Ogawa	2
11	Surgical challenges of Castleman's disease of the pelvis 2020 ·Urology Case Reports ·(unknown), (unknown), Yoshio Ogawa, Michio Naoe, (unknown), Jun Morita	2
12	Systematic review and two new cases of primary upper urinary tract neuroendocrine carcinomas 2018 ·Cancer Treatment and Research Communications ·(unknown), (unknown), Yuki Matsui, (unknown), (unknown), (unknown), Jun Morita, (unknown), Michio Naoe, (unknown), Hiroshi Ogura, (unknown), Toshiko Yamochi, Masafumi Takimoto, Yoshio Ogawa	3
13	Association between Vascular Lesion and Penile Erection Hardness in Japanese Patients with Erectile Dysfunction 2018 ·Urological Science ·(unknown), (unknown), Takashi Fukagai, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Atsushi Igarashi, (unknown), (unknown), Jun Morita, Michio Naoe, (unknown), Yoshio Ogawa	1
14	Pharmacokinetic Bioequivalence, Safety, and Immunogenicity of DMB-3111, a Trastuzumab Biosimilar, and Trastuzumab in Healthy Japanese Adult Males: Results of a Randomized Trial 2015 ·BioDrugs ·Jun Morita, Masashi Tanaka, Masahiro Nomoto, Shunji Matsuki, Tomomi Tsuru, Kyoko Matsuguma, Masanari Shiramoto	21
15	Evaluation of Hounsfield Units as a predictive factor for the outcome of extracorporeal shock wave lithotripsy and stone composition 2014 ·Urolithiasis ·(unknown), Jun Morita, Yoshio Ogawa	45
16	Bioequivalence in Safety and Pharmacokinetics of Fentanyl Tape for 3 Days after a Single Application in Japanese Healthy Male Subjects Co-Administrated Naltrexone Hydrochloride 2013 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Ken Shimada, Jun Morita	0
17	Antimicrobial activity of tebipenem pivoxil against Streptococcus Pneumoniae and Haemophilus Influenzae, and its pharmacokinetic-pharmacodynamic profile in mice 2009 ·(unknown), (unknown), (unknown), (unknown), Jun Morita, (unknown), Kazunori Maebashi, (unknown)	3
18	Zoledronate Stimulates γδ T Cells in Prostate Cancer Patients 2009 ·Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·Michio Naoe, Yoshio Ogawa, Kumiko Takeshita, Jun Morita, (unknown), (unknown), Takashi Fukagai, Sanju Iwamoto, Shuji Terao	34
19	Population Pharmacokinetics of Tebipenem Pivoxil (ME1211), a Novel Oral Carbapenem Antibiotic, in Pediatric Patients with Otolaryngological Infection or Pneumonia 2008 ·Drug Metabolism and Pharmacokinetics ·Nobuo Sato, (unknown), (unknown), (unknown), Jun Morita, Hisashi Suzuki, Hiroyuki Hayashi, (unknown), Tohru Kurosawa, Kyoichi Totsuka	26
20	Detection of circulating urothelial cancer cells in the blood using the CellSearch System 2007 ·Cancer ·Michio Naoe, Yoshio Ogawa, Jun Morita, (unknown), Kumiko Takeshita, (unknown), (unknown), Atsushi Igarashi, Atsushi Yanaihara, Sanju Iwamoto, Takashi Fukagai, Akira Miyazaki, Hideki Yoshida	119

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact